Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KineMatik Group, a provider of software solutions for managing scientific R&D knowledge, information and processes, has appointed Michael Jarjour as its new president and CEO.
Subscribe to our email newsletter
Before joining KineMatik, Mr Jarjour was vice president of global marketing at Organon. Previously, Mr Jarjour held key positions at top tier pharmaceutical organizations including Bristol-Myers Squibb, Pharmacia, Warner Lambert and Wyeth.
Mr Jarjour holds a BS in finance from Florida International University and an MBA from the Rutgers University.
Harry Lorton, chairman of the board of directors at KineMatik, said: “We are delighted to welcome Michael to the KineMatik team. His extensive experience in sales, marketing, operations and strategic planning, combined with his background and entrepreneurial skills in the life sciences and technology industries, will help us consolidate our position as leaders in the scientific enterprise content of management space.”